본문 바로가기

Successful rapid weight reduction and the use of liraglutide for morbid obesity in adolescent Prader-Willi syndrome

문서 유형
연구출판물 · 학술지 논문
등재
KCIScopus
저널 순위
Scopus Q3
피인용
Scopus 31KCI 4
FWCI (Scopus)
0
ISSN
2287-1012

저자

  1. Kim, Yoo-Mi제1저자교신저자Department of Pediatrics, Chungnam National University Hospital, Chung-nam National College of Medicine, Daejeon, Korea
  2. 이연주Department of Pediatrics, Pusan National University Children’s Hospital, Pusan National College of Medicine, Yangsan, Korea
  3. 김수연Department of Rehabilitation, Pusan National University Children’s Hospital, Pusan National College of Medicine, Yangsan, Korea
  4. 전종근Department of Pediatrics, Pusan National University Children’s Hospital, Pusan National College of Medicine, Yangsan, Korea
  5. Lim, Han HyukDepartment of Pediatrics, Chungnam National University Hospital, Chung-nam National College of Medicine, Daejeon, Korea

초록

Prader-Willi syndrome (PWS), an imprinting disorder, results from the loss of expression of a paternal gene on chromosome 15q11-q13. Progressive obesity and its associated complications lead to increased morbidity and early death in PWS patients. The management techniques available for morbid obesity in adolescents and adults with PWS are limited. Herein, we report successful weight reduction in an adolescent PWS case showing morbid obesity and respiratory failure. An 18-year-old girl with PWS presented with diffuse cellulitis and dyspnea due to severe obesity. Her body weight had increased from 146 to 161 kg despite dietary restriction to 800 kcal/day, and a mechanical ventilator was required for dyspnea. During mechanical ventilation, the patient was managed using diuretics and by restricting fluid intake; her daily calorie intake was reduced to 200 kcal. This aggressive calorie and water restriction continued for 3 weeks and reduced her body weight to 118.6 kg. After transfer to the general ward, the patient was provided with growth hormone therapy and intensive aquatic rehabilitation and was administered liraglutide; as a result, her weight further decreased to 104 kg (body mass index [BMI], 50.8 kg/m2), and she was discharged. Following discharge, she maintained her BMI and adapted to 1,000 kcal/day for 1 year. Aggressive water and calorie restriction were observed as an effective method for rapid weight reduction in PWS patients, and liraglutide appeared useful in maintaining weight reduction in adolescent and adult PWS.

키워드

AdolescentLiraglutideMorbidObesityPrader-Willi syndrome

식별자

Scopus EID
2-s2.0-85083098111
KCI
ART002572014